text
"['\n1. 요약재무정보\n가. 개별 재무정보\n1) 요약재무정보(개별)\xa0\n(단위 : 원 )\n구 분\n제67기 3분기\n제66기\n제65기\n[유동자산]\n57,971,235,693\n49,249,571,579\n70,498,286,259\nㆍ당좌자산\n52,391,866,293\n44,005,004,881\n66,146,502,267\nㆍ재고자산\n5,579,369,400\n5,244,566,698\n4,351,783,992\n[비유동자산]\n25,283,254,909\n31,800,648,488\n34,453,722,262\nㆍ투자자산\n9,087,725,613\n5,252,954,039\n7,072,214,209\nㆍ유형자산\n13,641,344,361\n14,971,872,727\n16,812,222,383\nㆍ무형자산\n272,561,541\n276,996,396\n470,440,456\nㆍ기타비유동자산\n2,281,623,394\n11,298,825,326\n10,098,845,214\n자산총계\n83,254,490,602\n81,050,220,067\n104,952,008,521\n[유동부채]\n3,482,065,250\n3,892,299,448\n13,644,112,827\n[비유동부채]\n6,272,875,769\n5,765,562,485\n8,120,158,181\n부채총계\n9,754,941,019\n9,657,861,933\n21,764,271,008\nㆍ자본금\n59,291,502,500\n59,291,502,500\n59,291,502,500\nㆍ자본잉여금\n9,530,092,969\n9,530,092,969\n9,530,092,969\nㆍ기타자본항목\n326,347,211\n135,872,342\n140,986,653\nㆍ이익잉여금(결손금)\n4,351,606,903\n2,434,890,323\n14,225,155,391\n자본총계\n73,499,549,583\n71,392,358,134\n83,187,737,513\n매출액\n21,616,635,841\n28,819,028,142\n26,276,462,476\n영업이익(손실)\n187,754,767\n1,452,807,025\n(3,780,753,830)\n법인세비용차감전순이익(손실)\n1,819,450,443\n(12,590,731,832)\n(3,361,205,253)\n당기순이익(손실)\n1,879,876,055\n(12,423,707,818)\n34,198,169,452\n기본주당이익\n16\n(105)\n288\n희석주당이익\n16\n(105)\n288\n연결에 포함된 회사수 \xa0 (단위 : 개)\n-\n-\n-\n※ 한국채택국제회계기준 작성기준에 따라 작성되었습니다.\n2) 재무제표 재작성-해당사항 없음.\n3) 당기에 신규로 연결재무제표에 포함된 종속기업이나 당기 중 연결재무제표의 작성대상에서 제외된 종속기업은 다음과 같습니다.\xa0\n회계기준\n제67기\n제66기\n제65기\n한국채택국제회계기준(K-IFRS)적용 시\n-\n-\n연결제외ORIENT SCIENCE & HEALTHCARE, INC.Orient Bioresource Center Inc\n4) 연결재무제표 작성 기준-해당사항 없음.\n']"
